Intermittent cancer pain: Clinical importance and an updated cancer pain classification

American Journal of Hospice and Palliative Medicine

Volumn 27, Issue 3, 2010, Pages 182-186

  Lasheen, Wael ^a   Walsh, Declan ^a   Sarhill, Nabeel ^a   Davis, Mellar ^a  

^a TAUSSIG CANCER INSTITUTE   (United States)

Author keywords

Breakthrough; Cancer; Classification; Intermittent; Pain

Indexed keywords

MORPHINE; NARCOTIC ANALGESIC AGENT;

ADULT; AGED; ALGORITHM; ARTICLE; CLASSIFICATION; DECISION TREE; DRUG ADMINISTRATION; EPIDEMIOLOGY; FEMALE; HOSPITALIZATION; HUMAN; INCIDENCE; MALE; METHODOLOGY; MIDDLE AGED; NEOPLASM; PAIN; PAIN ASSESSMENT; PALLIATIVE THERAPY; TIME; TREATMENT OUTCOME; UNITED STATES;

ADULT; AGED; AGED, 80 AND OVER; ALGORITHMS; ANALGESICS, OPIOID; CAUSALITY; DECISION TREES; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MORPHINE; NEOPLASMS; OHIO; PAIN; PAIN MEASUREMENT; PALLIATIVE CARE; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TREATMENT OUTCOME;

EID: 77952255163     PISSN: 10499091     EISSN: None     Source Type: Journal    
DOI: 10.1177/1049909109350206     Document Type: Article

References (25)

1. Twycross R., Fairfield S. Pain in far-advanced cancer. Pain. 1982; 14(3):303-310.
2. Portenoy R., Payne D., Jacobsen P. Breakthrough pain: characteristics and impact in patients with cancer pain. Pain. 1999;81(1-2): 129-134.
3. Bruera E., MacMillian K., Hanson J., MacDonald RN The Edmonton staging system for cancer pain: preliminary report. Pain. 1989;37(2):203-209.
4. Cleary J. Pharmacokinetic and pharmacodynamic issues in the treatment of break-through pain. Semin Oncol. 1997;24(5 suppl 16):S16-13-9.
5. Petzke K., Radbruch L., Zech D., Loick G., Grond S. Temporal presentation of chronic cancer pain: transitory pains on admission to a multidisciplinary pain clinic. J Pain Symptom Manage. 1999; 17(6):391-401.
6. Portenoy RK, Hagen NA Breakthrough pain: definition and management. Oncology. 1989;3(suppl 8):25-29.
7. Portenoy R., Hagen N. Breakthrough pain: definition, prevalence and characteristics. Pain. 1990;41(3):273-281.
8. Hanks G., Portenoy RK, MacDonald N., Forbes K. Difficult pain problems. In: Doyle D, Hanks GWC, MacDonald N, eds. Oxford Textbook of Palliative Medicine. 2nd ed. New York: Oxford University Press; 1998:454-477.
9. Coluzzi PH Cancer pain management: newer perspectives on opioids and episodic pain. Am J Hosp Palliat Care. 1998;15(1): 13-22.
10. Bennett D., Burton A., Fishman S.,et al.Consensus panel recommendations for the assessment and management of breakthrough pain. Part 1. Assessment. Pharm Ther. In press.
11. Abrahm JL Assessing the patient in pain. In: Abrahm JL, ed. A Physician's Guide to Pain and Symptom Management in Cancer Patients. 2nd ed. Baltimore, MD: Johns Hopkins University Press; 2005:107-147.
12. National Cancer Institute. Pain (PDQ®) Health Professional Version 2005. http://www.nci.nih.gov/cancertopics/pdq/supportivecare/pain/HealthProfes sional. Accessed December 12, 2005.
13. Payne R. Recognition and diagnosis of breakthrough pain. Pain Med. 2007;8(suppl 1):S3-S7.
14. Swanwick M., Haworth M., Lennard R. The prevalence of episodic pain in cancer: a survey of hospice patients on admission. Palliat Med. 2001;15(1):9-18.
15. Fine P., Busch M. Characterization of breakthrough pain by hospice patients and their caregivers. J Pain Symptom Manage. 1998;16(3):179-183.
16. Caraceni A., Martini C., Zecca E.,et al,and the Working Group of an IASP Task Force on Cancer Pain. Breakthrough pain characteristics and syndromes in patients with cancer pain. An international survey Palliat Med. 2004;18(3):177-183.
17. Mercadante S., Radbruch L., Caraceni A.,et al,and the Steering Committee of the European Association for Palliative Care (EAPC) Research Network. Episodic (breakthrough) pain: consensus conference of an expert working group of the European Association for Palliative Care. Cancer. 2002;94(3): 832-839.
18. Walsh D. Pharmacological management of cancer pain. Semin Oncol. 2000;27(1):45-63.
19. Twycross R. Pain relief. In: Twycross R, ed. Symptom Management in Advanced Cancer. Abingdon, Oxon: Radcliffe Medical Press; 1997:13-59.
20. Gutgsell T., Walsh D., Zhukovsky DS, Gonzales F., Lagman R. A prospective study of the pathophysiology and clinical characteristics of pain in a palliative medicine population. Am J Hospice Palliat Care. 2003;20(2):140-148.
21. Zepetella G., O'Doherty C., Collins S. Prevalence and characteristics of breakthrough pain in cancer patients admitted to a hospice. J Pain Symptom Manage. 2000;20(2):87-92.
22. Caraceni A., Portenoy RK An international survey of cancer pain characteristics and syndromes. IASP Task Force on Cancer Pain. International Association for the Study of Pain. Pain. 1999;82(3): 263-274.
23. Paice J. Pain. In: Groenwald SL, Frogge MH, Goodman M, Yarbro CH, eds. Cancer Symptom Management. Subury, MA: Jones and Bartlett Publishers; 1996:100-136.
24. WalshD. Oralmorphineinchroniccancerpain.Pain.1984;18(1):1-11.
25. Walsh D. Symptom control in patients with advanced cancer. Am J Hosp Palliat Care. 1990;7(6):20-29.